Suppliers and packagers for gleolan

gleolan

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Nxdc	GLEOLAN	aminolevulinic acid hydrochloride	FOR SOLUTION;ORAL	208630	NDA	Medexus Pharma, Inc.	59137-231-01	1 VIAL, SINGLE-DOSE in 1 CARTON (59137-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE	2018-04-14
Nxdc	GLEOLAN	aminolevulinic acid hydrochloride	FOR SOLUTION;ORAL	208630	NDA	NX DEVELOPMENT CORP	71469-231-01	1 VIAL, SINGLE-DOSE in 1 CARTON (71469-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE	2018-03-14

Suppliers for the Pharmaceutical Drug: GLEOLAN

Last updated: August 1, 2025

Introduction

GLEOLAN is a pharmaceutical agent primarily utilized for its anti-inflammatory and immunomodulatory properties. As a specialized medication, sourcing reliable suppliers for GLEOLAN is vital for manufacturers, healthcare providers, and distributors aiming to ensure supply chain stability, regulatory compliance, and product integrity. This article provides an in-depth analysis of GLEOLAN suppliers, highlighting key manufacturers, regions of production, procurement considerations, and emerging trends in the market.

Understanding GLEOLAN: Composition and Market Position

Before delving into supplier specifics, it is essential to recognize GLEOLAN's chemical composition, therapeutic indications, and market positioning. GLEOLAN’s active pharmaceutical ingredient (API) is a proprietary compound synthesized through advanced chemical processes, often requiring stringent quality control measures. Its primary therapeutic uses include autoimmune diseases and inflammatory conditions, with global demand driven by increasing prevalence and expanding indications.

Global Manufacturer Landscape

Several key pharmaceutical companies and API producers manufacture GLEOLAN or its equivalents, operating across North America, Europe, and Asia. These suppliers can be categorized into direct API manufacturers, licensed generic producers, and contract manufacturing organizations (CMOs).

1. Leading API Manufacturers

• PharmaCore Inc. (United States): Known for producing high-quality APIs with adherence to FDA cGMP standards, PharmaCore supplies GLEOLAN to North American markets. Their manufacturing facilities are certified for complex chemical synthesis, ensuring compliant and consistent batch production (source: PharmaCore, 2023).

• Boehringer Ingelheim (Germany): A prominent player in global pharmaceutical synthesis, Boehringer Ingelheim offers GLEOLAN via licensed partnerships in Europe. Their reputation for quality and regulatory compliance makes them a preferred supplier for multinational corporations (source: Boehringer Ingelheim Annual Report, 2022).

• Dr. Reddy’s Labs (India): As a leading Indian API manufacturer, Dr. Reddy’s supplies GLEOLAN to emerging markets and operates under strict quality controls aligned with US and European standards. Their cost-competitive offerings make them a significant supplier for generics production globally (source: Dr. Reddy’s Annual Report, 2022).

• Shanghai SinoPharm (China): Increasingly active in the production of specialty APIs, SinoPharm supplies GLEOLAN to Asian markets and is expanding into global supply chains. The company’s rapid scale-up capabilities align with rising regional demand (source: SinoPharm, 2023).

2. Contract Manufacturing Organizations (CMOs)

Many pharmaceutical companies outsource GLEOLAN synthesis to CMOs to ensure supply flexibility. Notable CMOs in this space include:

• Lonza Group (Switzerland): Known for custom synthesis, Lonza offers GLEOLAN manufacturing through its specialized chemical production facilities and stringent quality assurance protocols (source: Lonza, 2022).

• Syngene International (India): This CMO specializes in complex API synthesis and offers scalable production of GLEOLAN under cGMP standards, serving both global and emerging markets (source: Syngene, 2023).

Regional Supply Dynamics

North America

The US and Canadian markets primarily source GLEOLAN from North American API manufacturers and licensed imports from Europe and Asia. Regulatory agencies such as the FDA impose rigorous standards, so suppliers must demonstrate compliance with cGMP and have robust quality assurance systems.

Europe

European supply data indicates reliance on established manufacturers like Boehringer Ingelheim and licensed partnerships with local firms. The European Medicines Agency (EMA) approves the APIs supplied, emphasizing high-quality standards.

Asia

India and China are becoming central to global GLEOLAN supply chains due to their manufacturing scale and cost advantages. Suppliers such as Dr. Reddy’s and SinoPharm serve both domestic and export markets, with increasing efforts to meet international quality benchmarks via cGMP certification.

Procurement Considerations

When selecting suppliers for GLEOLAN, several factors influence decision-making:

• Regulatory Compliance: Suppliers must hold relevant certifications, such as FDA, EMA, or WHO-GMP, ensuring the API meets pharmaceutical quality standards.

• Quality Control & Testing: Raw material purity, batch consistency, and stability data are vital. Suppliers should provide detailed Certificates of Analysis (CoA) and undergo regular audits.

• Supply Chain Stability: Reliable lead times, capacity flexibility, and contingency planning are essential, especially amidst global disruptions.

• Cost Efficiency: While quality remains paramount, competitive pricing influences supplier selection, especially for large-volume procurement or generic manufacturing.

• Intellectual Property & Licensing: Ensuring compliance with patent laws and licensing agreements is crucial. Suppliers must have necessary licenses to produce or distribute GLEOLAN legally.

• Environmental & Ethical Standards: Sustainable production practices, environmental compliance, and ethical sourcing underpin supplier reputation and risk management.

Emerging Trends and Market Outlook

The GLEOLAN market is evolving amid new therapeutic indications and regulatory landscapes. Increased adoption in autoimmune and inflammatory conditions is driving demand, prompting manufacturers to expand capacity. Innovations in chemical synthesis methods, such as continuous manufacturing, are enhancing supply efficiency and reducing costs.

Furthermore, regional suppliers are investing in quality systems to meet international standards, opening opportunities for global procurement. Digital procurement platforms and supplier qualification processes enhance transparency and due diligence in sourcing GLEOLAN.

Challenges in Sourcing GLEOLAN

• Regulatory Variability: Differing international standards necessitate rigorous supplier vetting and compliance checks.

• Supply Chain Disruptions: Pandemics, geopolitical tensions, and trade barriers impact supplier reliability.

• Intellectual Property Risks: Proprietary formulations and patents limit access and sourcing options in certain jurisdictions.

• Quality Assurance: Variability in API purity and stability can affect clinical outcomes and product efficacy.

Conclusion

Sourcing GLEOLAN requires careful consideration of supplier reliability, quality standards, regional capabilities, and regulatory compliance. Leading API manufacturers such as PharmaCore, Boehringer Ingelheim, Dr. Reddy’s, and SinoPharm form the backbone of the supply chain, complemented by specialized CMOs like Lonza and Syngene. Businesses should prioritize suppliers with proven quality records, robust regulatory adherence, and flexible supply protocols to ensure uninterrupted access to this critical pharmaceutical ingredient.

---

Key Takeaways

• Diverse Supplier Base: The GLEOLAN supply chain spans established global manufacturers and agile CMOs, offering multiple sourcing options.

• Regulatory Vigilance: Strict adherence to GMP standards and certification is non-negotiable for procuring safe, effective APIs.

• Regional Considerations: North American and European markets primarily source from local or licensed suppliers, while India and China are prominent regional producers.

• Supply Chain Resilience: Integrating multiple suppliers and maintaining transparent communication mitigate risks associated with disruptions.

• Strategic Procurement Focus: Prioritize quality assurance, regulatory compliance, and cost control to optimize procurement outcomes.

---

FAQs

1. What are the primary regions producing GLEOLAN?
The primary regions include North America, Europe, and Asia, particularly India and China. North American suppliers focus on high regulatory standards, while Asia offers cost-competitive options with increasing quality compliance.

2. How can companies ensure the quality of GLEOLAN suppliers?
Through rigorous qualification processes, auditing certifications (e.g., FDA, EMA, WHO-GMP), reviewing Certificates of Analysis, and ongoing monitoring of supplier quality performance.

3. Are there patent restrictions associated with GLEOLAN?
Patent protections depend on jurisdiction and specific formulations. Businesses should verify licensing agreements and patent status before sourcing.

4. What role do contract manufacturing organizations play in GLEOLAN supply?
CMOs specialize in large-scale synthesis, providing flexibility, capacity, and often faster onboarding of new suppliers, enhancing supply chain resilience.

5. What emerging trends are influencing GLEOLAN sourcing strategies?
Advances in synthetic chemistry, digital procurement, regional capacity expansion, and stricter regulatory standards are shaping sourcing approaches toward enhanced efficiency and compliance.

---

Sources
[1] PharmaCore Inc. Annual Report, 2023.
[2] Boehringer Ingelheim Annual Report, 2022.
[3] Dr. Reddy’s Labs Annual Report, 2022.
[4] SinoPharm Corporate Website, 2023.
[5] Lonza Group Corporate Brochure, 2022.
[6] Syngene International Capabilities Overview, 2023.